---
schema_version: "secwatch.filing_event.v1"
accession: "0000883984-25-000006"
form_type: "8-K"
ticker: "ICUI"
cik: "0000883984"
company_name: "ICU MEDICAL INC/DE"
filed_at: "2025-02-27T23:59:59+00:00"
generated_at: "2026-05-26T02:56:08.789181+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# ICU Medical Q4 2024 revenue up 7% to $629.8M; adj. EPS $2.11 vs $1.57

## Summary
- Revenue $629.8M (+7% YoY); GAAP gross margin improved to 36.1% from 29.2%.
- GAAP net loss $(23.8)M ($(0.97)/share) vs $(17.1)M loss ($(0.71)) in Q4 2023.
- Adjusted diluted EPS $2.11 vs $1.57 YoY; Adjusted EBITDA $105.5M vs $86.3M.
- Company provided fiscal year 2025 guidance (detailed numbers not in excerpt).

## SEC filing metadata
- accession: 0000883984-25-000006
- form_type: 8-K
- ticker: ICUI
- cik: 0000883984
- company_name: ICU MEDICAL INC/DE
- filed_at: 2025-02-27T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/883984/000088398425000006/0000883984-25-000006-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/883984/000088398425000006/icui-20250227.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000883984-25-000006
- JSON: https://secwatch.observer/filing/0000883984-25-000006.json
- Plain text: https://secwatch.observer/filing/0000883984-25-000006.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.